CAGNAZZO, Celeste

CAGNAZZO, Celeste  

SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE  

Mostra records
Risultati 1 - 20 di 28 (tempo di esecuzione: 0.02 secondi).
Titolo Data di pubblicazione Autore(i) File
A phase I dose-escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. 2014 Aglietta M;Barone C;Sawyer MB;Moore MJ;Miller WH Jr;Bagalà C;Colombi F;Cagnazzo C;Gioeni L;Wang E;Huang B;Fly KD;Leone F
Adoptive immunotherapy against ovarian cancer 2016 Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio
Bacterial ligands as flexible and sensitive detectors in rapid tests for antibodies to SARS-CoV-2 2022 Simone Cavalera; Fabio Di Nardo; Matteo Chiarello; Thea Serra; Barbara Colitti; Cristina Guiotto; Franca Fagioli; Celeste Cagnazzo; Marco Denina; Annagloria Palazzo; Fiora Artusio; Roberto Pisano; Sergio Rosati; Claudio Baggiani; Laura Anfossi
Biliary tract carcinomas: From chemotherapy to targeted therapy. 2013 Marino D; Leone F; Cavalloni G; Cagnazzo C; Aglietta M.
Bureaucracy gives way to science. What good the pandemic has left 2020 Cagnazzo C.; Fagioli F.
Clinical research and burnout syndrome in Italy – only a physicians’ affair? 2021 Cagnazzo, Celeste; Filippi, Roberto; Zucchetti, Giulia; Cenna, Rosita; Taverniti, Cristiana; Guarrera, Agata Sue Ellen; Stabile, Stefano; Federici, Irene; Monti, Manuela; Pirondi, Sara; Testoni, Sara; Fagioli, Franca
Clinical research coordinators: A crucial resource 2019 Cagnazzo C.; Testoni S.; Guarrera A.S.; Stabile S.; Taverniti C.; Federici I.; Pirondi S.; Monti M.
Clinical research nurse in Italian centers: A mandatory figure? 2020 Martucci M.; Guarrera A.; Valente D.; Resente F.; Cagnazzo C.
Clinical research: Enough players to get out there? 2019 Cagnazzo C.; Guarrera A.; Cenna R.; Taverniti C.; Stabile S.; Federici I.; Pirondi S.; Testoni S.; Monti M.
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. 2018 Gobbini, Elisa; Pilotto, S; Pasello, G; Polo, V; Di Maio, M; Arizio, F; Galetta, D; Petrillo, P; Chiari, R; Matocci, R; Di Costanzo, A; Di Stefano Ts, ; Aglietta, Massimo; Cagnazzo, C; Sperduti, I; Bria, Emilio; Novello, Silvia
Fluoropyrimidine-induced cardiotoxicity 2018 Depetris, Ilaria; Marino, Donatella; Bonzano, Alessandro; Cagnazzo, Celeste; Filippi, Roberto; Aglietta, Massimo; Leone, Francesco
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience 2017 Marchesi, Emanuela; Cagnazzo, Celeste; Quattrini, Irene; Leopardi, Martina Piccinni; Villa, Chiara; Grignani, Giovanni; D'Ambrosio, Lorenzo; Stacchiotti, Silvia; Casali, Paolo Giovanni; Picci, Piero
Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy 2020 Pinto C.; Cagnazzo C.
Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future? 2021 Cagnazzo C.; Besse M.-G.; Manfellotto D.; Minghetti P.; Cazzaniga S.; Cottini L.; Fontanella A.; Maruti I.; Stabile S.; Testoni S.; Trogu P.; Sinno V.; Gussoni G.
A multitarget lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2 2021 Simone Cavalera; Barbara Colitti; Sergio Rosati; Gianmarco Ferrara; Luigi Bertolotti; Chiara Nogarol; Cristina Guiotto; Celeste Cagnazzo; Marco Denina; Franca Fagioli; Fabio Di Nardo; Matteo Chiarello; Claudio Baggiani; Laura Anfossi
New european clinical trial regulation: Perception and expectations in italy 2017 Cagnazzo C.; Campora S.; Ferretti E.; Arizio F.; Marchesi E.
New requirements for phase i trials: A challenge for I talian clinical research 2018 Marchesi E.; Monti M.; Nanni O.; Bassi L.; Piccinni-Leopardi M.; Cagnazzo C.
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study) 2016 Leone, Francesco; Marino, Donatella; Cereda, Stefano; Filippi, Roberto; Belli, Carmen; Spadi, Rosella; Nasti, Guglielmo; Montano, Massimo; Amatu, Alessio; Aprile, Giuseppe; Cagnazzo, Celeste; Fasola, Gianpiero; Siena, Salvatore; Ciuffreda, Libero; Reni, Michele; Aglietta, Massimo
Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases: The MetaPan study. 2013 Leone F;Artale S;Marino D;Cagnazzo C;Cascinu S;Pinto C;Fornarini G;Tampellini M;Di Fabio F;Sartore-Bianchi A;De Carlis L;Pugliese R;Capussotti L;Gioeni L;Siena S;Aglietta M
Patient associations and clinical oncology research: how much does a patient’s voice really matter? 2021 Franchina V.; Cagnazzo C.; Di Costanzo A.; Arizio F.; Frazzetto A.M.E.; Gori S.; Cenna R.; Nicolis F.; Procopio G.; Adamo V.; La Verde N.; Nanni O.